MERGER

Cohance Lifesciences merger with Suven Pharma gets NSE, BSE nod

A joint application by the Hyderabad-based Suven Pharmaceutical and Cohance Lifesciences has also been filed before the National Company Law Tribunal (NCLT) for the merger, the company said, adding that the expected timelines for the completion of the merger process were around 12-15 months.

More in MERGER

NCLT clears GSK-HUL merger, paves way for GSK Plc’s exit through huge block deal

Officials aware of the developments say Morgan Stanley is readying the share sale process.
NCLT approves the merger of assets of Max India into Max healthcare

According to Max healthcare 99.21% of the public shareholders voted in favour of the proposed scheme. Subsequently, the second motion petition is likely to be filed with NCLT soon. Max Healthcare and Advaita (to be renamed as Max India) are both expected to be listed on the Indian stock exchanges by March end, 2020.
NCLT okays merger of Monsanto India with Bayer CropScience

Bayer had in May received approval from the fair trade regulator Competition Commission of India (CCI), paving way for the completion of the global merger.
CVS defends settlement that allowed Aetna merger as judge assesses

The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc.
Eris Life to acquire Strides' India business for Rs 500 crore

Boards of both the companies are expected to meet on Saturday and a formal announcement is due as early as on Monday, people with knowledge of the matter said.